Enlivex Therapeutics Ltd (ENLV.O)

+ 收藏

资产负债表(Enlivex Therapeutics Ltd)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2025年中报2025年一季报2024年年报2024年三季报2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报
截止日期 2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-31
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表合并报表合并报表合并报表
报表年结日 1231123112311231123112311231123112311231
原始币种 美元美元美元美元美元美元美元美元美元美元
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后上市后上市后上市后
流动资产:
 现金及现金等价物(元) 会员可见会员可见会员可见会员可见3,747,000.001,913,000.00813,000.001,971,000.003,458,000.0013,138,000.00
 受限制存款及现金流动(元) 会员可见会员可见会员可见会员可见22,195,000.0021,523,000.0026,507,000.0028,527,000.0025,443,000.0022,839,000.00
 预付款项及其他应收款流动(元) 会员可见会员可见会员可见会员可见2,400,000.004,711,000.001,336,000.001,343,000.001,884,000.001,604,000.00
 流动资产其他项目(元) 会员可见会员可见会员可见会员可见228,000.00229,000.005,108,000.00---
 流动资产合计(元) 会员可见会员可见会员可见会员可见28,570,000.0028,376,000.0033,764,000.0031,841,000.0030,785,000.0037,581,000.00
非流动资产:
 物业、厂房及设备(元) 会员可见会员可见会员可见会员可见1,158,000.001,299,000.001,539,000.009,387,000.009,574,000.009,828,000.00
 受限制存款及现金非流动(元) --------7,159,000.007,252,000.00
 预付款项及其他长期应收款非流动(元) ----898,000.00-----
 非流动资产其他项目(元) 会员可见会员可见会员可见会员可见1,276,000.001,372,000.001,528,000.005,708,000.005,510,000.005,361,000.00
 非流动资产合计(元) 会员可见会员可见会员可见会员可见3,332,000.002,671,000.003,067,000.0015,095,000.0022,243,000.0022,441,000.00
总资产(元) 会员可见会员可见会员可见会员可见31,902,000.0031,047,000.0036,831,000.0046,936,000.0053,028,000.0060,022,000.00
流动负债:
 应付账款及票据(元) 会员可见会员可见会员可见会员可见303,000.00643,000.00827,000.00794,000.001,554,000.001,483,000.00
 其他应付款及应计费用(元) 会员可见会员可见会员可见会员可见2,538,000.002,966,000.004,001,000.003,545,000.003,437,000.003,970,000.00
 流动负债其他项目(元) --会员可见---1,233,000.00---
 流动负债合计(元) 会员可见会员可见会员可见会员可见2,841,000.003,609,000.006,061,000.004,339,000.004,991,000.005,453,000.00
非流动负债:
 非流动负债其他项目(元) 会员可见会员可见会员可见会员可见499,000.00587,000.00686,000.003,818,000.003,702,000.003,995,000.00
 非流动负债合计(元) 会员可见会员可见会员可见会员可见499,000.00587,000.00686,000.003,818,000.003,702,000.003,995,000.00
总负债(元) 会员可见会员可见会员可见会员可见3,340,000.004,196,000.006,747,000.008,157,000.008,693,000.009,448,000.00
股东权益:
 普通股(元) -会员可见会员可见会员可见-2,160,000.002,137,000.00-2,136,000.002,133,000.00
 股本溢价(元) 会员可见会员可见会员可见会员可见144,405,000.00139,823,000.00138,939,000.00138,539,000.00138,133,000.00137,583,000.00
 留存收益(元) 会员可见会员可见会员可见会员可见-119,329,000.00-116,233,000.00-112,093,000.00-102,998,000.00-97,035,000.00-90,243,000.00
 其他储备(元) ------1,101,000.00---
 累计其他全面收益(元) 会员可见会员可见会员可见会员可见1,101,000.001,101,000.00-1,101,000.001,101,000.001,101,000.00
 归属于母公司股东权益其他项目(元) 会员可见---2,385,000.00--2,137,000.00--
 归属于母公司股东权益(元) 会员可见会员可见会员可见会员可见28,562,000.0026,851,000.0030,084,000.0038,779,000.0044,335,000.0050,574,000.00
 股东权益合计(元) 会员可见会员可见会员可见会员可见28,562,000.0026,851,000.0030,084,000.0038,779,000.0044,335,000.0050,574,000.00
负债及股东权益合计(元) 会员可见会员可见会员可见会员可见31,902,000.0031,047,000.0036,831,000.0046,936,000.0053,028,000.0060,022,000.00
公告日期 2025-08-292025-05-302025-04-302024-11-292024-08-302024-06-142024-04-302023-11-092023-09-012023-06-16
会计准则 美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则
审计意见
核数师

前瞻产业研究院